biotechnology research

Reprogramming Tumour Biology

Duke Street Bio is focused on exploiting tumour genetic vulnerabilities and harnessing the natural power of the body’s immune system to fight cancer.

Next-Gen DDR Therapies

Duke Street Bio is developing the next generation of molecules targeting DNA Damage Repair (DDR) deficiencies in cancer.

Next Generation DDR

Next-Gen IO therapies

At Duke Street Bio we are developing proprietary molecules that convert immune-resistant ‘cold’ tumours to immunotherapy-responsive ‘hot’ tumours​. These molecules prime the immune system to relieve the brake applied by cancer and unleash the power of the anti-tumour immune response.​

Delivering life-saving cancer treatments to improve patient outcomes.

2 Duke St. London